Winston Ko, MBA CEO, Chairman of Board
Dorothy Ko, MS COO
J. Michael French, MS SVP Corporate Development
Raymond Chau, PhD Chief Scientist
Mark Kindy, Ph.D. Director of Scientific Research
Frank Young, MD Regulatory Advisor
PC Chan-Yu, PhD Clinical Research
Tony Shum, MD Medical Director
Lorraine DeCesare, RPh Clinical Trial Manager
James Collett, Esq. Patent Legal

In addition Genervon employs over 150 consultants, specialists and contract research organizations. The company is focused on streamlining the drug development process as much as possible through the use of contract research organizations (CROs). This strategy offers the benefits of fast delivery, higher levels of efficiency as well as lowered costs associated with drug development.

Copyright © 2017 Genervon Biopharmaceuticals, LLC. All rights reserved. All other trademarks or trade names are the property of their respective holders.